Ebos Sustainability Profile
Ebos Group Limited, commonly referred to as Ebos, is a leading healthcare and pharmaceutical company headquartered in Australia. Established in 1922, Ebos has grown to become a prominent player in the industry, with significant operations across New Zealand and Australia. The company focuses on the distribution of medical supplies, pharmaceuticals, and healthcare products, catering to hospitals, pharmacies, and aged care facilities. Ebos is renowned for its extensive product range, which includes medical consumables, surgical instruments, and pharmacy services, all distinguished by their quality and reliability. With a strong market position, Ebos has achieved notable milestones, including strategic acquisitions that have expanded its reach and capabilities. As a trusted partner in the healthcare sector, Ebos continues to innovate and adapt, ensuring it meets the evolving needs of its customers.
DitchCarbon Score
How does Ebos's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ebos's score of 25 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ebos's reported carbon emissions
In 2025, EBOS Group Limited reported total carbon emissions of approximately 18,654,000 kg CO2e, comprising 3,343,000 kg CO2e from Scope 1 and 15,311,000 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. For the previous year, 2024, EBOS's total emissions were approximately 19,884,000 kg CO2e, with Scope 1 emissions at 3,530,000 kg CO2e and Scope 2 emissions at 16,354,000 kg CO2e. In 2023, the total emissions were about 19,977,000 kg CO2e, with Scope 1 at 2,984,000 kg CO2e and Scope 2 at 16,993,000 kg CO2e. EBOS has not set specific reduction targets or initiatives as part of its climate commitments, and there are no emissions reduction targets reported under the Science Based Targets initiative (SBTi). The company’s emissions data is not cascaded from any parent organization, indicating that it operates independently in its reporting. Overall, EBOS Group Limited is actively monitoring its carbon footprint, focusing on Scope 1 and Scope 2 emissions, while continuing to assess its climate impact and commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Scope 1 | - | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 12,556,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
How Carbon Intensive is Ebos's Industry?
How Carbon Intensive is Ebos's Location?
Ebos's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ebos has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
